All news articles for September 2014

Sugardown's mode of action inhibits intestinal enzymes that free up glucose for ingested carbohydrates.

Boston Therapeutics launches blood sugar management supplement

By Hank Schultz

Boston Therapeutics (BTI) has entered the full commercialization phase of its Sugardown dietary supplement aimed at the healthy blood sugar management market.  The company is collaborating on the launch with Benchworks, a Maryland-based marketing firm.

Follow us

Featured Events

View more


View more